News for Photocure ASA (PHOO.OL)

PR NewswireOSLO, Norway, Feb. 19, 2025 OSLO, Norway, Feb. 19, 2025 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NO

Total Revenue: NOK145.4 million in Q2 2024.Hexvix/Cysview Revenue: NOK122 million in Q2 2024, a 6% increase year over year.Other Revenues: NOK23 million in Q2

Aug 07, 2024 / 12:00PM GMTDaniel Schneider - Photocure ASA - President, Chief Executive Officer All right. Well, welcome, everyone. Good afternoon. Good morning

Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting

Photocure ASA reported total group revenues of NOK 145.4 million and EBITDA of NOK 27.8 million in Q2 2024, with a cash balance of NOK 267.0 million.

Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.

Photocure ASA - Annual general meeting held

May 15, 2024 / 12:00PM GMTDan Schneider - Photocure ASA - President & CEO All right. Well, good afternoon, everyone. Good morning here in the US. My name is Dan

Photocure ASA: Results for the first quarter of 2024

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China

Innovative cervical dysplasia treatments drive market growth, backed by government programs & patient demand....

/PRNewswire/ -- The photodynamic therapy market size to grow by USD 2,053.68 million from 2022 to 2027, progressing at a CAGR of 8.22% during the forecast...

/PRNewswire/ -- The acne drugs market size is forecast to increase by USD 907.11 million from 2022 to 2027, at a CAGR of 3.46%, according to the recent market...

Incumbent director of Fancamp, Peter H. Smith, who, together with joint actors James Hunter and his affiliates, Mark Fekete and Heather Hannan, hold in aggregate, directly and indirectly an aggregate...

OSLO, Norway, March 3, 2021 /PRNewswire/ -- Photocure ASA (OSE: PHO) reports Hexvix®/Cysview® revenues of NOK 97.7 million in the fourth quarter o...

OSLO, Norway, Jan. 26, 2021 /PRNewswire/ -- Photocure ASA (PHO:OSE): The Bladder Cancer Company focused on delivering transformative solutions to improve ...